HB1652

Pennsylvania HB1652 amends the Newborn Child Testing Act to include Gaucher disease in the newborn screening program.

Pennsylvania HB1652 amends the Newborn Child Testing Act to expand the Newborn Child Screening and Follow-up Program. The bill adds Gaucher disease to the list of conditions for which newborn screening and follow-up services are provided. This change aims to assist health care providers in determining necessary treatment or services to prevent intellectual disability, physical disability, or death. The program will be established by the department, with approval from the Newborn Screening and Follow-up Technical Advisory Board.